Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 11.517\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) CC(=O)NS(=O)(=O)c1ccc(NC(=O)CC(C)c2ccccc2)cc1
b) CCOc1ccc(C2CC(c3cccc(Cl)c3)n3nc(N)nc3N2)cc1
c) O=C(CN1C(=O)c2ccccc2C1=O)Oc1ccc(F)cc1
Answer: b. CCOc1ccc(C2CC(c3cccc(Cl)c3)n3nc(N)nc3N2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(C2CC(c3cccc(Cl)c3)n3nc(N)nc3N2)cc1
CCOc1ccc(C2CC(c3cccc(Cl)c3)n3nc(N)nc3N2)cc1
7-(3-chlorophenyl)-5-(4-ethoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine